CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully RNA-encoded, site-specific gene-integration system, presented at the Cold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback